Viatris Inc. Common Stock (VTRS) is a publicly traded Healthcare sector company. As of May 21, 2026, VTRS trades at $16.49 with a market cap of $19.22B and a P/E ratio of -63.67. VTRS moved +2.75% today. Year to date, VTRS is +34.11%; over the trailing twelve months it is +86.82%. Its 52-week range spans $6.85 to $17.53. Analyst consensus is buy with an average price target of $17.14. Rallies surfaces VTRS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes VTRS SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $16.49 |
| Market Cap | $19.22B |
| P/E Ratio | -63.67 |
| EPS | $-0.26 |
| Dividend Yield | 0.12% |
| 52-Week High | $17.53 |
| 52-Week Low | $6.85 |
| Volume | 8.56M |
| Avg Volume | 0 |
| Revenue (TTM) | $14.56B |
| Net Income | $-296.50M |
| Gross Margin | 34.40% |
7 analysts cover VTRS: 0 strong buy, 4 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $17.14.